approval
savePOLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 6
- approvaltrastuzumab emtansine: KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalMar 26, 2026
- approvalfaricimab: VABYSMO (FARICIMAB-SVOA) — FDA approvalApr 9, 2026
- approvalinavolisib: ITOVEBI (INAVOLISIB) — FDA approvalApr 15, 2026
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalFeb 10, 2026
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalFeb 10, 2026
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalJan 21, 2026
comments(0)
5-min edit window · permanent after that